Ann: Technology License and Clinial Development Program Agreement, page-6

Dixon's report 30 Oct - re cure for "patent's" with back problems - Kt009. Why wasn't this reported in Bishop's annual report only 4 days earlier - lack of communication or some other reason ?

Re Dixon's exciting new product announcement - the combination of two, old unproven products/ideas has failure written all over it - syringe patent 2006 - Kt009 patent 2007 (syringe only a drawing with a number) - not much of a choice out of the seventy odd products they assessed. I can't see this happening in my lifetime.